Clearing the Way: Navigating Treatment Advances in Atopic Dermatitis
Today, there are an increasing number of targeted, systemic therapies available to treat moderate to severe atopic dermatitis (AD), thanks to a greater understanding of the pathophysiology of this disease. In this one-hour activity, you’ll learn about these treatment advances in AD and how to apply them in your own practice through shared decision-making with your patients. Led by three thought leaders in AD care, “Clearing the Way” takes you through four educational modules that cover the evolving clinical practice guidelines, present, and future systemic therapies, assessing the impact of AD and treatment outcomes, and collaborative care and decision making. Stay up to date on innovative therapies that can help clear the way for your patients with AD!
Fresh insights from the Alzheimer’s Association International Conference 2022
From July 31-August 4, 2022, thousands attended the Alzheimer’s Association International Conference (AAIC) in San Diego, where new research on Alzheimer’s disease (AD) was shared and discussed. If you weren’t at AAIC or you would like to revisit it, this activity shares conference highlights and, over six modules, translates this information into what it can mean for the future of AD care.
Over four modules, this activity covers the evolving epidemiology of AD, tools and biomarkers for early identification of AD, and emerging efficacy and safety data for new AD disease-modifying therapies. In the last two modules, a multidisciplinary faculty team discusses two patient cases focused on the early symptomatic stages, early detection, and treatment of AD.
With the understanding that the pathophysiological process of AD starts years before the first clinical symptom appears, now’s the time to stay up-to-date on the latest developments in the early detection and treatment of AD.
Turning Talk Into Treatment: Applying New Evidence To Shared Decisions In Psoriatic Arthritis Care
Despite advances in treatment, navigating the rapidly evolving therapeutic landscape of psoriatic arthritis (PsA) can be challenging for both clinicians and their patients. Turning Talk Into Treatment is designed to help bridge the gap between available treatment options and patient care to enable clinicians to find a clear way forward.
In this one-hour and fifteen minute activity, two rheumatology faculty members will share the latest treatment recommendations from the American College of Rheumatology, the National Psoriasis Foundation, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. They’ll also explain the latest evidence from clinical trials. Then, learn how you can use shared decision making with your patients to help them consider new treatment options. Turning Talk Into Treatment can help you put the latest advances in psoriatic arthritis care into your practice.
Explore Outcomes from Our Past ActivitiesLearn More
“Team members planning meetings were well-organized and concise. They were also highly adaptable, making relevant changes in a timely manner to meet the needs of the audience.”